Geode Capital Management
TNXP icon

Geode Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.31M Buy
175,212
+113,175
+182% +$4.07M ﹤0.01% 2607
2025
Q1
$1.11M Sell
62,037
-1,909,857
-97% -$34.2M ﹤0.01% 3271
2024
Q4
$650K Buy
1,971,894
+1,855,907
+1,600% +$612K ﹤0.01% 3523
2024
Q3
$17.2K Buy
115,987
+99,441
+601% +$14.8K ﹤0.01% 4413
2024
Q2
$11.5K Sell
16,546
-382,160
-96% -$267K ﹤0.01% 4530
2024
Q1
$74.2K Buy
398,706
+292,095
+274% +$54.3K ﹤0.01% 4241
2023
Q4
$43K Sell
106,611
-19,686
-16% -$7.94K ﹤0.01% 4384
2023
Q3
$68.9K Buy
126,297
+40,932
+48% +$22.3K ﹤0.01% 4344
2023
Q2
$135K Sell
85,365
-448,146
-84% -$708K ﹤0.01% 4221
2023
Q1
$315K Buy
533,511
+161,659
+43% +$95.6K ﹤0.01% 3840
2022
Q4
$144K Buy
371,852
+27,892
+8% +$10.8K ﹤0.01% 4251
2022
Q3
$183K Buy
343,960
+211,110
+159% +$112K ﹤0.01% 4264
2022
Q2
$209K Sell
132,850
-7,482,408
-98% -$11.8M ﹤0.01% 4235
2022
Q1
$1.75M Buy
7,615,258
+414,647
+6% +$95.5K ﹤0.01% 3318
2021
Q4
$2.58M Sell
7,200,611
-222,715
-3% -$79.6K ﹤0.01% 3255
2021
Q3
$4.46M Buy
7,423,326
+1,901,592
+34% +$1.14M ﹤0.01% 2971
2021
Q2
$6.13M Buy
5,521,734
+2,625,017
+91% +$2.91M ﹤0.01% 2777
2021
Q1
$3.71M Buy
2,896,717
+1,971,887
+213% +$2.52M ﹤0.01% 2931
2020
Q4
$624K Buy
924,830
+207,120
+29% +$140K ﹤0.01% 3523
2020
Q3
$602K Buy
717,710
+611,091
+573% +$513K ﹤0.01% 3377
2020
Q2
$65K Buy
106,619
+22,147
+26% +$13.5K ﹤0.01% 3943
2020
Q1
$59K Buy
+84,472
New +$59K ﹤0.01% 3892
2019
Q4
Sell
-16,399
Closed -$6K 4232
2019
Q3
$6K Hold
16,399
﹤0.01% 4189
2019
Q2
$22K Hold
16,399
﹤0.01% 4155
2019
Q1
$39K Hold
16,399
﹤0.01% 4050
2018
Q4
$36K Sell
16,399
-22,315
-58% -$49K ﹤0.01% 4038
2018
Q3
$22K Hold
38,714
﹤0.01% 4091
2018
Q2
$172K Buy
+38,714
New +$172K ﹤0.01% 3760
2017
Q2
Sell
-10,209
Closed -$47K 4109
2017
Q1
$47K Sell
10,209
-91,501
-90% -$421K ﹤0.01% 3954
2016
Q4
$47K Buy
101,710
+264
+0.3% +$122 ﹤0.01% 3920
2016
Q3
$70K Sell
101,446
-9,738
-9% -$6.72K ﹤0.01% 3880
2016
Q2
$221K Buy
111,184
+16,260
+17% +$32.3K ﹤0.01% 3554
2016
Q1
$228 Sell
94,924
-66
-0.1% ﹤0.01% 3587
2015
Q4
$728K Buy
94,990
+17,301
+22% +$133K ﹤0.01% 3072
2015
Q3
$410K Buy
+77,689
New +$410K ﹤0.01% 3310